
Marine Biotechnology Market Report 2026
Global Outlook – By Type (Bio Active Substance, Bio Materials), By Source (Corals And Sponges, Algae, Marine Viruses, Marine Fungi, Other Sources), By Technology (Isolation And Cultivation of Microorganisms, Culture-Independent Techniques), By Application (Aquaculture And Food Products, Environment And Human Health, Drug Discovery ), By End User (Medical And Pharmaceutical, Food Industry, Cosmetic Industry, Chemical Industry, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035
Marine Biotechnology Market Overview
• Marine Biotechnology market size has reached to $6.6 billion in 2025 • Expected to grow to $9.64 billion in 2030 at a compound annual growth rate (CAGR) of 8% • Growth Driver: The Impact Of Rising Biofuel Production On The Growth Of The Marine Biotechnology Market • Market Trend: Hi-Q Marine Biotech Launches OliFuco RE A Breakthrough In Sarcopenia Management And Muscle Regeneration • Europe was the largest region in 2025.What Is Covered Under Marine Biotechnology Market?
Marine biotechnology is a branch of science that involves the utilization of marine creatures, their genetic material, and related bioactive substances for various uses. Marine biotechnology encompasses the study and manipulation of marine organisms, including plants, animals, and microorganisms, to develop products, processes, and technologies to be used in cosmetics, nutritional supplements, pharmaceuticals, and other industries. The main types of marine biotechnological products are bioactive substances and biomaterials. Bioactive substances refer to a wide range of biological, pharmacological, and nutraceutical activities and are considered to have beneficial effects on nutrition and health. It includes various sources, such as corals and sponges, algae, marine viruses, marine fungi, and others. Several types of technologies include isolation and cultivation of microorganisms and culture-independent techniques. These are used for several applications, including aquaculture and food products, the environment and human health, and drug discovery, and are used by several end-users, such as medical and pharmaceutical, the food industry, the cosmetic industry, the chemical industry, and others.
What Is The Marine Biotechnology Market Size and Share 2026?
The marine biotechnology market size has grown strongly in recent years. It will grow from $6.6 billion in 2025 to $7.1 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to growing scientific interest in marine organisms, increasing demand for natural bioactive compounds, expansion of marine research initiatives, rising pharmaceutical and cosmetic applications, development of marine resource utilization technologies.What Is The Marine Biotechnology Market Growth Forecast?
The marine biotechnology market size is expected to see strong growth in the next few years. It will grow to $9.64 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to increasing investment in marine biotech R&D, rising focus on advanced drug discovery from marine sources, growing nutraceutical and cosmetic industry demand, expanding environmental and health biotechnology applications, stronger emphasis on sustainable marine resource exploitation. Major trends in the forecast period include increasing exploration of marine derived bioactive compounds, rising focus on marine based pharmaceutical development, growing utilization of marine resources in nutraceutical production, expansion of marine biotechnology applications in healthcare, increasing emphasis on sustainable marine biological research.Global Marine Biotechnology Market Segmentation
1) By Type: Bio Active Substance, Bio Materials 2) By Source: Corals And Sponges, Algae, Marine Viruses, Marine Fungi, Other Sources 3) By Technology: Isolation And Cultivation of Microorganisms, Culture-Independent Techniques 4) By Application: Aquaculture And Food Products, Environment And Human Health, Drug Discovery 5) By End User: Medical And Pharmaceutical, Food Industry, Cosmetic Industry, Chemical Industry, Other End Users Subsegments: 1) By Bio Active Substance: Marine-Derived Pharmaceuticals, Nutraceuticals, Enzymes 2) By Bio Materials: Biopolymers, Bio-Composite Materials, Bio-Based CoatingsWhat Is The Driver Of The Marine Biotechnology Market?
The rise in biofuel production is expected to boost the growth of the marine biotechnology market going forward. Biofuel refers to a type of renewable energy derived from organic materials, such as plants, crops, and microorganisms, that undergo biological processes to produce fuels suitable for combustion. Marine biotechnology contributes to the development of biofuels, offering eco-friendly alternatives in response to the increasing demand for renewable energy. For instance, in October 2025, U.S. Energy Information Administration (EIA), is the US-Based independent statistical agency, in U.S. biofuel output weakened in 2024, with production capacity rising by only 3% from early 2024 to early 2025. Therefore, the rise in biofuel production is driving the growth of the marine biotechnology industry.Key Players In The Global Marine Biotechnology Market
Major companies operating in the marine biotechnology market report are Cyanotech Corporation, CP Kelco US Inc., PharmaMar S.A., Nofima A.S., NovaMatrix, GlycoMar Ltd., SEPPIC Inc., Marinova Pty. Ltd., Prolume Ltd., Aker BioMarine Antarctic AS, Tequesta Bioventures LLC, Marinomed Biotech AG, AstaReal Co. Ltd., Euglena Co. Ltd., Earthrise Nutritionals LLC, Bluebiotech International GmbH, Nutrex Hawai Inc., Kepley Biosystems Incorporated, Finless Foods Inc., Jellagen Pty Ltd, KnipBio Inc.Global Marine Biotechnology Market Trends and Insights
Major companies operating in the marine biotechnology market are focusing on developing innovative products, such as bioactive marine-derived nutraceuticals, to address age-related health conditions and enhance tissue regeneration. Bioactive marine-derived nutraceuticals are natural compounds extracted from marine sources, such as seaweed or algae, that provide health benefits beyond basic nutrition by supporting physiological functions like muscle regeneration, immunity, and reducing inflammation. For instance, in September 2024, Hi-Q Marine Biotech International Ltd, a Taiwan-based biotechnology company, launched OliFuco RE, a product for managing sarcopenia and promoting tissue regeneration, targeting age-related muscle loss. OliFuco RE is a low molecular weight fucoidan powder derived from brown seaweed, recognized for its bioactive properties. It enhances muscle regeneration, significantly improving muscle mass and strength in older adults. This scientifically-backed formulation offers a promising solution for combating sarcopenia, marking a potential breakthrough in nutraceuticals aimed at muscle preservation and regeneration.What Are Latest Mergers And Acquisitions In The Marine Biotechnology Market?
In September 2024, Blue Future Holding, a Norway-based investment management company, acquired full ownership of GreenFox Marine for an undisclosed amount. This acquisition enhances Blue Future Holding’s strategy to expand its portfolio in the aquaculture sector and aligns with its commitment to investing in sustainable seafood solutions. GreenFox Marine is a Norway-based company, specializes in developing advanced technologies for the aquaculture industry, with a focus on automated sex sorting of salmon.Regional Outlook
Europe was the largest region in the marine biotechnology market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Marine Biotechnology Market?
The marine biotechnology market includes revenues earned by entities by providing services such as bioprospecting and bioactive compound discovery, genetic analysis and genomic studies, bioprocessing, fermentation, pharmaceutical discovery, and materials technology. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Marine Biotechnology Market Report 2026?
The marine biotechnology market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the marine biotechnology industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Marine Biotechnology Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $7.1 billion |
| Revenue Forecast In 2035 | $9.64 billion |
| Growth Rate | CAGR of 7.5% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Source, Technology, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Cyanotech Corporation, CP Kelco US Inc., PharmaMar S.A., Nofima A.S., NovaMatrix, GlycoMar Ltd., SEPPIC Inc., Marinova Pty. Ltd., Prolume Ltd., Aker BioMarine Antarctic AS, Tequesta Bioventures LLC, Marinomed Biotech AG, AstaReal Co. Ltd., Euglena Co. Ltd., Earthrise Nutritionals LLC, Bluebiotech International GmbH, Nutrex Hawai Inc., Kepley Biosystems Incorporated, Finless Foods Inc., Jellagen Pty Ltd, KnipBio Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
